The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bowden Christopher since year 2005.
The trader's CIK number is 1608601.
At the time of this reporting, Bowden Christopher is the Chief Medical Officer of Agios Pharmaceuticals Inc .
(stock ticker symbol AGIO).
See this page for all insider trading activities at Agios Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-02-16||AGIO||Agios Pharmaceuticals Inc||Sale||2,000||77.80||155,590|
|2018-02-16||AGIO||Agios Pharmaceuticals Inc||Option Ex||2,000||35.16||70,320|
|2018-02-01||AGIO||Agios Pharmaceuticals Inc||Option Ex||2,000||35.16||70,320|
|2018-02-01||AGIO||Agios Pharmaceuticals Inc||Sale||2,000||78.86||157,730|
|2017-09-11||AGIO||Agios Pharmaceuticals Inc||Option Ex||6,000||35.16||210,959|
|2017-09-11||AGIO||Agios Pharmaceuticals Inc||Sale||6,000||65.00||390,000|
|2015-06-01||AGIO||Agios Pharmaceuticals Inc||Option Ex||5,000||35.16||175,799|
|2015-06-01||AGIO||Agios Pharmaceuticals Inc||Sale||5,000||120.67||603,350|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bowden Christopher (Chief Medical Officer of Agios Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.